Abstract: The invention relates to proteins having multi-specific binding abilities by fusion of an OB-fold variant, in particular from the Sac7d family, to the light or heavy chain of an antibody.
Type:
Grant
Filed:
November 13, 2018
Date of Patent:
March 19, 2024
Assignee:
AFFILOGIC
Inventors:
Olivier Kitten, Mathieu Cinier, Simon Huet